TY - JOUR
T1 - Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador
AU - Guevara, Rommel
AU - Prado-Vivar, Belén
AU - Márquez, Sully
AU - Muñoz, Erika B.
AU - Carvajal, Mateo
AU - Guadalupe, Juan José
AU - Becerra-Wong, Mónica
AU - Proaño, Stefanie
AU - Bayas-Rea, Rosa
AU - Coloma, Josefina
AU - Grunauer, Michelle
AU - Trueba, Gabriel
AU - Rojas-Silva, Patricio
AU - Barragán, Verónica
AU - Cárdenas, Paúl
N1 - Publisher Copyright:
Copyright © 2022 Guevara, Prado-Vivar, Márquez, Muñoz, Carvajal, Guadalupe, Becerra-Wong, Proaño, Bayas-Rea, Coloma, Grunauer, Trueba, Rojas-Silva, Barragán and Cárdenas.
PY - 2022/9/9
Y1 - 2022/9/9
N2 - SARS-CoV-2 reinfection is defined as a new infection with a different virus variant in an individual who has already recovered from a previous episode of COVID-19. The first case of reinfection in the world was described in August 2020, since then, reinfections have increased over time and their incidence has fluctuated with specific SARS-CoV-2 variant waves. Initially, reinfections were estimated to represent less than 1% of total COVID-19 infections. With the advent of the Omicron variant, reinfections became more frequent, representing up to 10% of cases (based on data from developed countries). The frequency of reinfections in Latin America has been scarcely reported. The current study shows that in Ecuador, the frequency of reinfections has increased 10-fold following the introduction of Omicron, after 22 months of surveillance in a single center of COVID-19 diagnostics. Suspected reinfections were identified retrospectively from a database of RT-qPCR-positive patients. Cases were confirmed by sequencing viral genomes from the first and second infections using the ONT MinION platform. Monthly surveillance showed that the main incidence peaks of reinfections were reached within four to five months, coinciding with the increase of COVID-19 cases in the country, suggesting that the emergence of reinfections is related to higher exposure to the virus during outbreaks. This study performed the longest monitoring of SARS-CoV-2 reinfections, showing an occurrence at regular intervals of 4-5 months and confirming a greater propensity of Omicron to cause reinfections.
AB - SARS-CoV-2 reinfection is defined as a new infection with a different virus variant in an individual who has already recovered from a previous episode of COVID-19. The first case of reinfection in the world was described in August 2020, since then, reinfections have increased over time and their incidence has fluctuated with specific SARS-CoV-2 variant waves. Initially, reinfections were estimated to represent less than 1% of total COVID-19 infections. With the advent of the Omicron variant, reinfections became more frequent, representing up to 10% of cases (based on data from developed countries). The frequency of reinfections in Latin America has been scarcely reported. The current study shows that in Ecuador, the frequency of reinfections has increased 10-fold following the introduction of Omicron, after 22 months of surveillance in a single center of COVID-19 diagnostics. Suspected reinfections were identified retrospectively from a database of RT-qPCR-positive patients. Cases were confirmed by sequencing viral genomes from the first and second infections using the ONT MinION platform. Monthly surveillance showed that the main incidence peaks of reinfections were reached within four to five months, coinciding with the increase of COVID-19 cases in the country, suggesting that the emergence of reinfections is related to higher exposure to the virus during outbreaks. This study performed the longest monitoring of SARS-CoV-2 reinfections, showing an occurrence at regular intervals of 4-5 months and confirming a greater propensity of Omicron to cause reinfections.
KW - COVID-19
KW - SARS-CoV-2
KW - genomic epidemiology
KW - reinfection
KW - sequencing
UR - http://www.scopus.com/inward/record.url?scp=85138600006&partnerID=8YFLogxK
U2 - 10.3389/fcimb.2022.951383
DO - 10.3389/fcimb.2022.951383
M3 - Artículo
C2 - 36164552
AN - SCOPUS:85138600006
SN - 2235-2988
VL - 12
JO - Frontiers in Cellular and Infection Microbiology
JF - Frontiers in Cellular and Infection Microbiology
M1 - 951383
ER -